(43) The mean change in the KCCQ-CS score in the PRESERVED-HF and EMPEROR-Preserved studies indicated statistically significant benefits of SGLT2 inhibitors for improving health status, but no statistically significant benefit was found in the EMPERIAL-Preserved trial (9, 14, 15). The gene discussed is SLC5A2; the disease is hydrops fetalis.